Adenosine kinase, epilepsy and stroke: mechanisms and therapies

Trends in Pharmacological Sciences

Volumn 27, Issue 12, 2006, Pages 652-658

  Boison, Detlev ^a  

^a LEGACY RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' DEOXY 5 IODOTUBERCIDIN; ADENOSINE; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE KINASE; ADENOSINE KINASE INHIBITOR; ADENOSINE RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ACUTE BRAIN DISEASE; ANTICONVULSANT ACTIVITY; ASTROCYTOSIS; BRAIN DEVELOPMENT; BRAIN FUNCTION; CELL PROLIFERATION; CELL TRANSPLANTATION; DOWN REGULATION; DRUG SAFETY; ELECTROENCEPHALOGRAM; EMBRYONIC STEM CELL; EPILEPSY; FOCAL EPILEPSY; HUMAN; MOTOR COORDINATION; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SEIZURE; STEM CELL; STEM CELL TRANSPLANTATION; STROKE; TRAUMATIC BRAIN INJURY;

ADENOSINE; ADENOSINE KINASE; ANIMALS; BRAIN; CEREBROVASCULAR ACCIDENT; DRUG DELIVERY SYSTEMS; ENZYME INHIBITORS; EPILEPSY; HUMANS;

EID: 33750943168     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2006.10.008     Document Type: Review

References (62)

1. Fredholm B.B., et al. Adenosine and brain function. Int. Rev. Neurobiol. 63 (2005) 191-270
2. Fredholm B.B., et al. Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs. Annu. Rev. Pharmacol. Toxicol. 45 (2005) 385-412
3. Boison D. Adenosine and epilepsy: from therapeutic rationale to new therapeutic strategies. Neuroscientist 11 (2005) 25-36
4. Cunha R.A. Neuroprotection by adenosine in the brain: from A1 receptor activation to A2A receptor blockade. Purinergic Signaling 1 (2005) 111-134
5. Ribeiro J.A. What can adenosine neuromodulation do for neuroprotection?. Curr. Drug Targets CNS Neurol. Disord. 4 (2005) 325-329
6. Jacobson K.A., and Gao Z.G. Adenosine receptors as therapeutic targets. Nat. Rev. Drug Discov. 5 (2006) 247-264
7. Baldwin S.A., et al. The equilibrative nucleoside transporter family, SLC29. Pflugers Arch. 447 (2004) 735-743
8. Gray J.H., et al. The concentrative nucleoside transporter family, SLC28. Pflugers Arch. 447 (2004) 728-734
9. Kong W., et al. Mammalian nucleoside transporters. Curr. Drug Metab. 5 (2004) 63-84
10. Carrier E.J., et al. Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 7895-7900
11. Dale N. Resetting intrinsic purinergic modulation of neural activity: an associative mechanism?. J. Neurosci. 22 (2002) 10461-10469
12. Kowaluk E.A., and Jarvis M.F. Therapeutic potential of adenosine kinase inhibitors. Expert Opin. Investig. Drugs 9 (2000) 551-564
13. Zimmermann H. Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch. Pharmacol. 362 (2000) 299-309
14. Huber A., et al. Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 7611-7616
15. Pak M.A., et al. Inhibition of adenosine kinase increases endogenous adenosine and depresses neuronal activity in hippocampal slices. Neuropharmacology 33 (1994) 1049-1053
16. Arch J.R., and Newsholme E.A. Activities and some properties of 5′-nucleotidase, adenosine kinase and adenosine deaminase in tissues from vertebrates and invertebrates in relation to the control of the concentration and the physiological role of adenosine. Biochem. J. 174 (1978) 965-977
17. Gouder N., et al. Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis. J. Neurosci. 24 (2004) 692-701
18. Studer F.E., et al. Shift of adenosine kinase expression from neurons to astrocytes during postnatal development suggests dual functionality of the enzyme. Neuroscience 142 (2006) 125-137
19. Dunwiddie T.V., and Masino S.A. The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci. 24 (2001) 31-55
20. Burnstock G. Purinoceptors: Ontogeny and phylogeny. Drug Dev. Res. 39 (1996) 204-242
21. McNally T., et al. Cloning and expression of the adenosine kinase gene from rat and human tissues. Biochem. Biophys. Res. Commun. 231 (1997) 645-650
22. Fredholm B.B., et al. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev. 51 (1999) 83-133
23. Dunwiddie T.V. Adenosine and suppression of seizures. Adv. Neurol. 79 (1999) 1001-1010
24. Moshe S.L. Seizures early in life. Neurology 55 Suppl. 1 (2000) S15-S20
25. Wong M. Advances in the pathophysiology of developmental epilepsies. Semin. Pediatr. Neurol. 12 (2005) 72-87
26. Pearson T., et al. Sustained elevation of extracellular adenosine and activation of A(1) receptors underlie the post-ischaemic inhibition of neuronal function in rat hippocampus in vitro. J. Neurochem. 97 (2006) 1357-1368
27. Lynch III J.J., et al. Inhibition of adenosine kinase during oxygen-glucose deprivation in rat cortical neuronal cultures. Neurosci. Lett. 252 (1998) 207-210
28. Pascual O., et al. Astrocytic purinergic signaling coordinates synaptic networks. Science 310 (2005) 113-116
29. Serrano A., et al. GABAergic network activation of glial cells underlies hippocampal heterosynaptic depression. J. Neurosci. 26 (2006) 5370-5382
30. Vanore G., et al. Seizure activity produces differential changes in adenosine A1 receptors within rat hippocampus. Neurochem. Res. 26 (2001) 225-230
31. Haydon P.G., and Carmignoto G. Astrocyte control of synaptic transmission and neurovascular coupling. Physiol. Rev. 86 (2006) 1009-1031
32. Liberto C.M., et al. Pro-regenerative properties of cytokine-activated astrocytes. J. Neurochem. 89 (2004) 1092-1100
33. Brambilla R., et al. Blockade of A2A adenosine receptors prevents basic fibroblast growth factor-induced reactive astrogliosis in rat striatal primary astrocytes. Glia 43 (2003) 190-194
34. Rebola N., et al. Long-term effect of convulsive behavior on the density of adenosine A1 and A 2A receptors in the rat cerebral cortex. Epilepsia 46 Suppl. 5 (2005) 159-165
35. Ekonomou A., et al. Reduction of A1 adenosine receptors in rat hippocampus after kainic acid-induced limbic seizures. Neurosci. Lett. 284 (2000) 49-52
36. 1 receptor density and of adenosine neuromodulation in the hippocampus of kindled rats. Eur. J. Neurosci. 18 (2003) 820-828
37. 2 to cortical excitability via pH. Neuron 48 (2005) 1011-1023
38. Hasko G., et al. Adenosine receptor signaling in the brain immune system. Trends Pharmacol. Sci. 26 (2005) 511-516
39. Boison D., et al. Neonatal hepatic steatosis by disruption of the adenosine kinase gene. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 6985-6990
40. Fedele D.E., et al. Astrogliosis in epilepsy leads to overexpression of adenosine kinase resulting in seizure aggravation. Brain 128 (2005) 2383-2395
41. Sun D., et al. Mediation of tubuloglomerular feedback by adenosine: evidence from mice lacking adenosine 1 receptors. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 9983-9988
42. Johansson B., et al. Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 9407-9412
43. Kukley M., et al. The role of extracellular adenosine in regulating mossy fiber synaptic plasticity. J. Neurosci. 25 (2005) 2832-2837
44. Kochanek P.M., et al. Adenosine A1 receptor knockout mice develop lethal status epilepticus after experimental traumatic brain injury. J. Cereb. Blood Flow Metab. 26 (2006) 565-575
45. 1 receptors are crucial in keeping an epileptic focus localized. Exp. Neurol. 200 (2006) 184-190
46. Plamondon H., et al. Mutually protective actions of kainic acid epileptic preconditioning and sublethal global ischemia on hippocampal neuronal death: involvement of adenosine A1 receptors and K(ATP) channels. J. Cereb. Blood Flow Metab. 19 (1999) 1296-1308
47. de Mendonca A., et al. Adenosine: does it have a neuroprotective role after all?. Brain Res. Brain Res. Rev. 33 (2000) 258-274
48. Pignataro G., et al. Transgenic overexpression of adenosine kinase aggravates cell death in ischemia. J. Cereb. Blood Flow Metab (2006). http://www.nature.com/jcbfm/index.html 10.1038/sj.jcbfm.9600334
49. Kowaluk E.A., et al. Adenosine kinase inhibitors. Curr. Pharm. Des. 4 (1998) 403-416
50. Britton D.R., et al. Site and event specific increase of striatal adenosine release by adenosine kinase inhibition in rats. Neurosci. Lett. 266 (1999) 93-96
51. Jarvis M.F., et al. Comparison of the ability of adenosine kinase inhibitors and adenosine receptor agonists to attenuate thermal hyperalgesia and reduce motor performance in rats. Pharmacol. Biochem. Behav. 73 (2002) 573-581
52. Boyer S.H., et al. Adenosine kinase inhibitors. 5. Synthesis, enzyme inhibition, and analgesic activity of diaryl-erythro-furanosyltubercidin analogues. J. Med. Chem. 48 (2005) 6430-6441
53. McGaraughty S., et al. Anticonvulsant and antinociceptive actions of novel adenosine kinase inhibitors. Curr. Top. Med. Chem. 5 (2005) 43-58
54. Nilsen K.E., and Cock H.R. Focal treatment for refractory epilepsy: hope for the future?. Brain Res. Brain Res. Rev. 44 (2004) 141-153
55. Raedt R., and Boon P. Cell therapy for neurological disorders: A comprehensive review. Acta Neurol. Belg. 105 (2005) 158-170
56. Thompson K.W. Genetically engineered cells with regulatable GABA production can affect afterdischarges and behavioral seizures after transplantation into the dentate gyrus. Neuroscience 133 (2005) 1029-1037
57. Fredholm B.B. Adenosine and neuroprotection. Int. Rev. Neurobiol. 40 (1997) 259-280
58. 1 receptor activation in a mouse model of pharmacoresistant epilepsy. Epilepsia 44 (2003) 877-885
59. 1 receptor desensitization after focal long-term delivery of adenosine by encapsulated myoblasts. Exp. Neurol. 193 (2005) 53-64
60. Ruschenschmidt C., et al. Functional properties of ES cell-derived neurons engrafted into the hippocampus of adult normal and chronically epileptic rats. Epilepsia 46 Suppl. 5 (2005) 174-183
61. Fedele D.E., et al. Engineering embryonic stem cell derived glia for adenosine delivery. Neurosci. Lett. 370 (2004) 160-165
62. Güttinger M., et al. Suppression of kindled seizures by paracrine adenosine release from stem cell derived brain implants. Epilepsia 46 (2005) 1-8